Pharmaceuticals
A trust-driven sector where ESG scrutiny now extends deep into manufacturing and sourcing.
Sector landscape
What we typically see in pharmaceuticals.
Pharmaceutical companies face a uniquely visible ESG profile: energy-intensive facilities, complex global supply chains, water-intensive processes, and a stakeholder base — payers, regulators, patients — increasingly attentive to how medicine is made.
Emerging regulations
- IFRS S1/S2 and BRSR
- CSDDD supply-chain due diligence
- Facility-level emissions regulation
Market expectations
- Healthcare-system procurement criteria
- Investor ESG screening
- Supply-chain transparency
Relevant services
The four services most often combined for this sector.
Discuss what's happening in pharmaceuticals with a sector advisor.
A senior advisor will respond within one business day. Confidential, no obligation.